FdaApplication

BLA 125476

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTakeda Pharmaceuticals U.S.A., Inc.
application_typeBLA
approval_date2014-05-20

Products (1)

ProductActive ingredientStrengthDosage form
ENTYVIOVEDOLIZUMAB300MGFor Injection

1 product